Drug Profile
West Nile virus vaccine - Najit Technologies
Alternative Names: HydroVax-001Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Najit Technologies
- Developer National Institute of Allergy and Infectious Diseases
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported West Nile virus infections
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for phase-I development in West Nile virus infections(Prevention) in USA (IM, Injection)
- 28 Aug 2020 No recent reports of development identified for preclinical development in West Nile virus infections(Prevention) in USA (Parenteral)
- 06 Jul 2016 Preclinical trials in West Nile virus infections (Prevention) in USA (Parenteral)